Anna Hyatt is an Executive Director and the Head of Intellectual Property, Risk & Compliance at Dren Bio, Inc., where they have been since 2025. With 17 years of experience in the biopharmaceutical industry and law firms, they possess deep expertise in oncology, autoimmunity, tolerance, microbiome, and immunology, particularly in large molecule and antibody engineering. Previously, Anna served as a Senior Patent Agent at Genentech and held positions at Darby & Darby and Fish & Richardson, P.C. Anna earned a Ph.D. in Immunology from Yale University and a B.A. in Molecular & Cell Biology from UC Berkeley.
This person is not in the org chart
This person is not in any teams
This person is not in any offices